NEW YORK, Oct. 27 (GenomeWeb News) - Shares in Third Wave Technologies were down 16.3 percent in early-afternoon trading as investors slammed the company despite beating top-line projections for the third quarter.

 

Third Wave's stock was trading down $1.30 at $6.70 on the Nasdaq exchange after nosediving to $5.97 in 30 minutes of heavy trading after the market opened.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.